EU Approves Hospira's Inflectra In Biosimilars Milestone
Hospira Inc. on Tuesday said the European Commission has approved Inflectra, its copycat version of Johnson & Johnson's blockbuster biologic drug Remicade, marking a historic day for development of highly advanced...To view the full article, register now.
Already a subscriber? Click here to view full article